Ocular Therapeutix, Inc.
OCUL
$11.87
-$0.43-3.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 25.81% | -37.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 25.81% | -37.37% | |||
| Cost of Revenue | 20.19% | 4.50% | |||
| Gross Profit | -18.39% | -32.96% | |||
| SG&A Expenses | -7.94% | 19.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.69% | 10.28% | |||
| Operating Income | -5.83% | -26.38% | |||
| Income Before Tax | -5.87% | -32.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.87% | -32.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.87% | -32.37% | |||
| EBIT | -5.83% | -26.38% | |||
| EBITDA | -5.85% | -26.83% | |||
| EPS Basic | -3.91% | -31.28% | |||
| Normalized Basic EPS | -3.98% | -31.28% | |||
| EPS Diluted | -3.39% | -31.94% | |||
| Normalized Diluted EPS | -3.98% | -31.28% | |||
| Average Basic Shares Outstanding | 1.89% | 0.82% | |||
| Average Diluted Shares Outstanding | 1.89% | 0.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||